Resmed 

€213.10
579
+€0.50+0.24%Friday 07:05

Statistics

Day High
213.1
Day Low
213.1
52W High
230.6
52W Low
157.95
Volume
0
Avg. Volume
2
Mkt Cap
29.97B
P/E Ratio
23.68
Dividend Yield
1.1%
Dividend
2.35

Upcoming

Dividends

1.1%Dividend Yield
Sep 2026
€0.58
Jun 2026
€0.52
Mar 2026
€0.52
Dec 2025
€0.51
Sep 2025
€0.51
10Y Growth
6.82%
5Y Growth
9.9%
3Y Growth
8.29%
1Y Growth
8.87%

Earnings

Jan 28Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
2.29
2.43
2.56
2.69
Expected EPS
2.6872436597999996
Actual EPS
N/A

Financials

26.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.87BRevenue
1.31BNet Income

Analyst Ratings

$186.75Average Price Target
The highest estimate is ⁦218.53⁩.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
30%
Hold
70%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RME.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Koninklijke Philips N.V.
PHG
Mkt Cap26.31B
Philips Respironics, a subsidiary of Philips, competes directly with ResMed in the sleep and respiratory care market, offering CPAP machines, ventilators, and other respiratory products.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare is a leading manufacturer of respiratory care products, including CPAP devices and humidifiers, directly competing with ResMed's product offerings.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers a range of medical devices that compete with ResMed, particularly in the ventilation and monitoring systems for respiratory conditions.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes with ResMed in the medical device sector, particularly in areas of sleep and respiratory care through its various healthcare solutions.
GE Aerospace
GE
Mkt Cap313.14B
General Electric, through its healthcare division, provides medical devices and technologies that compete with ResMed's offerings, including respiratory care and sleep solutions.
Smith & Nephew
SNN
Mkt Cap12.43B
Smith & Nephew, while primarily known for orthopedics, competes with ResMed through its products in the medical equipment sector, including devices for wound management that can intersect with care for sleep-related conditions.
Stryker
SYK
Mkt Cap111.95B
Stryker competes with ResMed in the broader medical technology and devices market, offering products that can be used in surgical and critical care settings which may overlap with ResMed's market.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet, primarily focused on musculoskeletal healthcare, competes with ResMed in the medical device market, offering products that can indirectly affect sleep and respiratory health.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, known for its robotic surgical systems, competes with ResMed in the broader healthcare technology space, offering innovative solutions that can impact the treatment of conditions related to sleep and respiratory care.

About

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
Show More
CEO
Michael J. Farrell
Employees
11370
Country
United States
ISIN
US7611521078
WKN
000895878

Listings

0 Comments

Share your thoughts

FAQs

What is Resmed stock price today?▼
The current price of RME.MU is €213.10 EUR — it has increased by +0.24% in the past 24 hours. Watch Resmed stock price performance more closely on the chart.
What is Resmed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Resmed stocks are traded under the ticker RME.MU.
Is Resmed stock price growing?▼
RME.MU stock has fallen by -5.75% compared to the previous week, the month change is a +7.82% rise, over the last year Resmed has showed a -1.25% decrease.
What is Resmed market cap?▼
Today Resmed has the market capitalization of 29.97B
When is the next Resmed earnings date?▼
Resmed is going to release the next earnings report on January 28, 2027.
What were Resmed earnings last quarter?▼
RME.MU earnings for the last quarter are 2.6 EUR per share, whereas the estimation was 2.4 EUR resulting in a +8.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Resmed revenue for the last year?▼
Resmed revenue for the last year amounts to 4.87B EUR.
What is Resmed net income for the last year?▼
RME.MU net income for the last year is 1.31B EUR.
Does Resmed pay dividends?▼
Yes, RME.MU dividends are paid quarterly. The last dividend per share was 0.58 . As of today, Dividend Yield (FWD)% is 1.1%.
How many employees does Resmed have?▼
As of November 7, 2026, the company has 11,370 employees.
In which sector is Resmed located?▼
Resmed operates in the Health & Wellness sector.
When did Resmed complete a stock split?▼
The last stock split for Resmed was on August 31, 2010 with a ratio of 2:1.
Where is Resmed headquartered?▼
Resmed is headquartered in SAN DIEGO, United States.